Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Kramer

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
American Journal of Diseases of Children (1960)|December 1, 1980
Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapyR Wientzen, C B Prestidge, R I Kramer, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 22, 2021
Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofenEmma E J Kasteel, Leonie S Lautz, Maxime Culot, et al.
International Journal of Systematic Bacteriology|November 11, 1999
Ornithinicoccus hortensis gen. nov., sp. nov., a soil actinomycete which contains L-ornithineI Groth, P Schumann, K Martin, et al.
Journal of Agricultural and Food Chemistry|December 22, 2023
Use of Physiologically Based Kinetic Modeling to Predict Deoxynivalenol Metabolism and Its Role in Intestinal Inflammation and Bile Acid Kinetics in HumansJingxuan Wang, Veronique de Bruijn, Ivonne M C M Rietjens, et al.
CJC Open|November 25, 2024
Genetic Testing for Familial Hypercholesterolemia: The Current State of Its Implementation in CanadaAdam I Kramer, Susan Christian, Kirsten Bartels, et al.
Pediatric Infectious Disease|July 1, 1986
Comparison of piperacillin vs. ticarcillin plus tobramycin in the treatment of acute pulmonary exacerbations of cystic fibrosisM A Jackson, H Kusmiesz, S Shelton, et al.
Toxicology|December 1, 2025
A next generation physiologically-based kinetic model for quantitative in vitro to in vivo extrapolation of cisplatin-induced nephrotoxicity in humansKiri G J Romano Olmedo, Jiaqi Chen, Ivonne M C M Rietjens, et al.
The Journal of Nervous and Mental Disease|June 1, 1985
Assessment of tardive dyskinesia using the Abnormal Involuntary Movement ScaleR D Lane, W M Glazer, T E Hansen, et al.
Regulatory Toxicology and Pharmacology : RTP|November 11, 2022
Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFateStyliani Fragki, Aldert H Piersma, Joost Westerhout, et al.
Environmental Science & Technology|March 19, 2025
Next Generation Risk Assessment of Acute Neurotoxicity from Organophosphate Exposures Using the In Vitro-In Silico Derived Dietary Comparator RatioJiaqi Chen, Thijs M J A Moerenhout, Nynke I Kramer, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
American Journal of Diseases of Children (1960)|December 1, 1980
Acute pulmonary exacerbations in cystic fibrosis. A double-blind trial of tobramycin and placebo therapyR Wientzen, C B Prestidge, R I Kramer, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 22, 2021
Application of in vitro data in physiologically-based kinetic models for quantitative in vitro-in vivo extrapolation: A case-study for baclofenEmma E J Kasteel, Leonie S Lautz, Maxime Culot, et al.
International Journal of Systematic Bacteriology|November 11, 1999
Ornithinicoccus hortensis gen. nov., sp. nov., a soil actinomycete which contains L-ornithineI Groth, P Schumann, K Martin, et al.
Journal of Agricultural and Food Chemistry|December 22, 2023
Use of Physiologically Based Kinetic Modeling to Predict Deoxynivalenol Metabolism and Its Role in Intestinal Inflammation and Bile Acid Kinetics in HumansJingxuan Wang, Veronique de Bruijn, Ivonne M C M Rietjens, et al.
CJC Open|November 25, 2024
Genetic Testing for Familial Hypercholesterolemia: The Current State of Its Implementation in CanadaAdam I Kramer, Susan Christian, Kirsten Bartels, et al.
Pediatric Infectious Disease|July 1, 1986
Comparison of piperacillin vs. ticarcillin plus tobramycin in the treatment of acute pulmonary exacerbations of cystic fibrosisM A Jackson, H Kusmiesz, S Shelton, et al.
Toxicology|December 1, 2025
A next generation physiologically-based kinetic model for quantitative in vitro to in vivo extrapolation of cisplatin-induced nephrotoxicity in humansKiri G J Romano Olmedo, Jiaqi Chen, Ivonne M C M Rietjens, et al.
The Journal of Nervous and Mental Disease|June 1, 1985
Assessment of tardive dyskinesia using the Abnormal Involuntary Movement ScaleR D Lane, W M Glazer, T E Hansen, et al.
Regulatory Toxicology and Pharmacology : RTP|November 11, 2022
Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFateStyliani Fragki, Aldert H Piersma, Joost Westerhout, et al.
Environmental Science & Technology|March 19, 2025
Next Generation Risk Assessment of Acute Neurotoxicity from Organophosphate Exposures Using the In Vitro-In Silico Derived Dietary Comparator RatioJiaqi Chen, Thijs M J A Moerenhout, Nynke I Kramer, et al.
Pageof 16